GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Olympus Corp (TSE:7733) » Definitions » EV-to-EBIT

Olympus (TSE:7733) EV-to-EBIT

: 28.64 (As of Today)
View and export this data going back to 1949. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Olympus's Enterprise Value is 円2,457,911 Mil. Olympus's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was 円85,825 Mil. Therefore, Olympus's EV-to-EBIT for today is 28.64.

The historical rank and industry rank for Olympus's EV-to-EBIT or its related term are showing as below:

TSE:7733' s EV-to-EBIT Range Over the Past 10 Years
Min: 12.12   Med: 27.82   Max: 100.8
Current: 28.64

During the past 13 years, the highest EV-to-EBIT of Olympus was 100.80. The lowest was 12.12. And the median was 27.82.

TSE:7733's EV-to-EBIT is ranked worse than
64.1% of 468 companies
in the Medical Devices & Instruments industry
Industry Median: 19.3 vs TSE:7733: 28.64

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Olympus's Enterprise Value for the quarter that ended in Dec. 2023 was 円2,342,133 Mil. Olympus's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was 円85,825 Mil. Olympus's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 3.66%.


Olympus EV-to-EBIT Historical Data

The historical data trend for Olympus's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Olympus Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-EBIT
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 56.05 22.61 36.96 20.69 16.10

Olympus Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.46 16.10 15.55 21.71 27.29

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Olympus's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Olympus EV-to-EBIT Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Olympus's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Olympus's EV-to-EBIT falls into.



Olympus EV-to-EBIT Calculation

Olympus's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=2457910.623/85825
=28.64

Olympus's current Enterprise Value is 円2,457,911 Mil.
Olympus's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円85,825 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Olympus  (TSE:7733) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Olympus's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=85825/2342133.32
=3.66 %

Olympus's Enterprise Value for the quarter that ended in Dec. 2023 was 円2,342,133 Mil.
Olympus's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円85,825 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Olympus EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Olympus's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Olympus (TSE:7733) Business Description

Traded in Other Exchanges
Address
Shinjuku Monolith, 2-3-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, JPN, 163-0914
Olympus Corp manufactures and sells precision instruments for the healthcare industry. The firm operates in three segments: scientific solutions, imaging, and medical. The scientific solutions segment sells microscopes and other imaging tools to life sciences and industrial customers. The imaging segment sells digital cameras under the Olympus brand. The medical segment supplies medical equipment, including gastrointestinal and surgical endoscopes and endotherapy devices. This segment generates the vast majority of revenue. Sales in Asia and North America contribute the largest proportions of revenue.

Olympus (TSE:7733) Headlines

No Headlines